ClinicalTrials.gg
RecruitingNCT05630508LIVENUpdated Jun 26, 2025

Lifestyle Management App for Adults With Diabetes Type

An interventional study of interactive Mhealth Lifestyle behavior intervention and Sham in Diabetes Mellitus, Type 2, sponsored by Princess Nourah Bint Abdulrahman University. Recruiting at 1 site in Saudi Arabia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-26.

Sponsored by Princess Nourah Bint Abdulrahman University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Oct 2022; still recruiting 4 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will evaluate whether the 12-week health coaching mobile application (LIVEN) will succeed in enhancing lifestyle behaviors in adults with Type 2 Diabetes compared to typical treatment. The mobile application's viability will be assessed in 2 parts; the first part is testing easiness and friendliness of using Liven by the patient and health coach. The second part is evaluating the suitability of Liven education material for the patients and whether the coaching program results in enhancing lifestyle behaviors and blood sugar levels. the investigators hypothesize that the 12-week online lifestyle-coaching program will be viable, and a full-scale study can proceed.

Read the detailed description

This study will investigate the feasibility of a 12-weeks online lifestyle (nutrition and physical behavior) coaching program through a mobile app (LIVEN) compared to standard treatment for people with type 2 diabetes. This study will be done in two phases; the first phase is the usability study (phase1), in which the user friendliness of the application will be assessed, and any technical flaws will be resolved prior and during the second phase. The second phase of the study will consist of adapting a diabetes educational material and assessing the feasibility of the program (phase2). the investigators hypothesize that the 12-week online lifestyle-coaching program will be feasible, and a full-scale study can proceed.

02

Conditions studied

  • Diabetes Mellitus, Type 2

Keywords

  • Type 2 diabetes management
  • Mhealth lifestyle management program
03

In context

Diabetes Mellitus, Type 2

10,371 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,406 are open to participants now.

This study's planned enrollment of 90 is above the median of 80 across 8,350 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Princess Nourah Bint Abdulrahman University is the lead sponsor of 31 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults, aged 18 years or older
  • Arabic speakers
  • Capable of utilizing smartphones
  • Diagnosed with T2DM
  • Poor glycemic control: A1c > 7.5%

Exclusion criteria

Exclusion Criteria:

  • Individuals using insulin injection
  • Individuals suffering from disorders that might affect intervention (e.g. amputation, enucleation of the eye, or end-stage kidney disease)
  • Women who are pregnant or breastfeeding
  • Individuals diagnosed with other types of diabetes (such as type I or MODY)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    interactive mhealth Lifestyle behavior intervention

    Receiving Standard care, LIVEN educational material and interactive LIVEN application

    Behavioral: interactive Mhealth Lifestyle behavior intervention

  • Sham comparator
    Sham group - app access only

    Receiving standard care, LIVEN educational material and access to the application

    Other: Sham

  • No intervention
    Control group - Standard care

    Receiving Standard care only

Interventions

  • Behavioralinteractive Mhealth Lifestyle behavior intervention

    Receiving Standard care, LIVEN educational material and interactive LIVEN application, via having a human component which is a health coach for 3 months

  • OtherSham

    Receiving standard care, LIVEN educational material and access to the application

06

What researchers measure

Primary outcomes

  1. recruitment rate - descriptive

    reported as the number of participants' consented divide by the number of people that were invited to participate

    Time frame: immediately after the intervention (3 months)

  2. retention rates

    reported as the number of participants completing all study sessions

    Time frame: immediately after the intervention (3 months)

  3. User friendliness

    will be assessed via user engagement tracking in the app

    Time frame: Daily application engagement data for each patient will be analyzed once at the end of the patient's 12 week program.

Secondary outcomes

  1. Glycemic control - A1c

    will be assess via A1c blood test will be reported as percentage. higher % indicate worse outcome

    Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention

  2. Glycemic control - continuous glucose mentoring (CGM)

    will be assess via continuous glucose mentoring (CGM) as variability. higher variability indicates worse outcome

    Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention

  3. Body composition - fat free mass (%) physiological parameter

    will be assessed via Bioelectrical Impedance Analysis (BIA). fat free mass (%) will reported as percentage. higher % indicate better outcome

    Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention

  4. Lifestyle behaviors - Health-Promoting Lifestyle profile II (Questionnaire)

    will be assessed via Health-Promoting Lifestyle profile II. HPLP-II is a 4-point Likert scale with 52 items including six subscales: health responsibility, physical activity, nutrition, spiritual growth, interpersonal relationships, and stress management. scores range from 52 to 208. higher scores indicate better outcome.

    Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention

  5. physical performance assessments - upper body muscle strength in kg

    will be assessed via Hand Grip Strength using dynameter (power in kg), higher scores indicate higher physical performance

    Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention

  6. physical performance assessments - lower body muscle strength in counts

    will be assessed via Sit to Stand Test (count), higher counts indicate higher physical performance

    Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention

  7. physical performance assessments - endurance

    will be assessed via 6-minute walk test (distance in m). higher distance indicates higher endurance

    Time frame: will be assessed one week prior to the intervention and one week after the end of the intervention

07

Study locations

1 of 1 sites recruiting
  • Princess Nourah bint Abdulrahman University
    Riyadh, Riyadh Region 11321, Saudi Arabia
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05630508
Lead sponsor
Princess Nourah Bint Abdulrahman University
Collaborators
Liven
Responsible party
Shaima Alothman (Research Scientist, Clinical Assistant Professor, Princess Nourah Bint Abdulrahman University) — Principal investigator
First posted
Nov 29, 2022
Start date
Oct 1, 2022
Primary completion
Sep 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jun 26, 2025

Study contacts

Shaima A Alothman, PhD
Contact
shaalothman@pnu.edu.sa
+966503952053

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion